CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.

IF 78.5 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

New England Journal of Medicine Pub Date : 2025-09-25 DOI:10.1056/nejmc2508023

Fabian Müller,Raja Atreya,Simon Völkl,Michael Aigner,Sascha Kretschmann,Soraya Kharboutli,Moritz Leppkes,Selina Sitte,Deike Strobel,Arndt Hartmann,Saurabh Mehandru,Jean-Frederic Colombel,Georg Schett,Andreas Mackensen,Markus F Neurath

引用次数: 0

查看原文本刊更多论文

CD19 CAR - t细胞治疗耐多药溃疡性结肠炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

New England Journal of Medicine 医学-医学：内科

CiteScore

145.40

自引率

0.60%

发文量

1839

审稿时长

1 months

期刊介绍： The New England Journal of Medicine (NEJM) stands as the foremost medical journal and website worldwide. With an impressive history spanning over two centuries, NEJM boasts a consistent publication of superb, peer-reviewed research and engaging clinical content. Our primary objective revolves around delivering high-caliber information and findings at the juncture of biomedical science and clinical practice. We strive to present this knowledge in formats that are not only comprehensible but also hold practical value, effectively influencing healthcare practices and ultimately enhancing patient outcomes.